NASDAQ
Evaxion Biotech A/S (EVAX) has a fcf yield of -21.78% as of Friday, May 29, 2026. This represents a 79.85% increase compared to its 12-month average of -108.09%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.